Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne A Phillips

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Pathology|August 2, 2020
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinomaJovana R Gotovac, David Sh Liu, Michael J Yates, et al.
Cancer Research|September 27, 2017
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast CancerZhi Ling Teo, Stephanie Versaci, Sathana Dushyanthen, et al.
Gut|July 19, 2015
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinomaDavid S H Liu, Matthew Read, Carleen Cullinane, et al.
Cancer Research|September 3, 2004
The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancerTing Ling Lo, Permeen Yusoff, Chee Wai Fong, et al.
Oncoimmunology|June 5, 2013
Human perforin mutations and susceptibility to multiple primary cancersJoseph A Trapani, Kevin Y T Thia, Miles Andrews, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 28, 2021
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's EsophagusJovana R Gotovac, Tanjina Kader, Julia V Milne, et al.
Molecular Cancer Therapeutics|July 28, 2021
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation StatusKenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, et al.
Oncotarget|November 19, 2016
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasisDavid S Liu, Sanne J M Hoefnagel, Oliver M Fisher, et al.
Neuro-Oncology|May 3, 2018
PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding proteinPaul M Daniel, Gulay Filiz, Daniel V Brown, et al.
Cell Death & Disease|March 1, 2024
Caspase-2 protects against ferroptotic cell deathSwati Dawar, Mariana C Benitez, Yoon Lim, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Pathology|August 2, 2020
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinomaJovana R Gotovac, David Sh Liu, Michael J Yates, et al.
Cancer Research|September 27, 2017
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast CancerZhi Ling Teo, Stephanie Versaci, Sathana Dushyanthen, et al.
Gut|July 19, 2015
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinomaDavid S H Liu, Matthew Read, Carleen Cullinane, et al.
Cancer Research|September 3, 2004
The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancerTing Ling Lo, Permeen Yusoff, Chee Wai Fong, et al.
Oncoimmunology|June 5, 2013
Human perforin mutations and susceptibility to multiple primary cancersJoseph A Trapani, Kevin Y T Thia, Miles Andrews, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 28, 2021
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's EsophagusJovana R Gotovac, Tanjina Kader, Julia V Milne, et al.
Molecular Cancer Therapeutics|July 28, 2021
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than <i>TP53</i> Mutation StatusKenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, et al.
Oncotarget|November 19, 2016
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasisDavid S Liu, Sanne J M Hoefnagel, Oliver M Fisher, et al.
Neuro-Oncology|May 3, 2018
PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding proteinPaul M Daniel, Gulay Filiz, Daniel V Brown, et al.
Cell Death & Disease|March 1, 2024
Caspase-2 protects against ferroptotic cell deathSwati Dawar, Mariana C Benitez, Yoon Lim, et al.
Pageof 10